Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers AG (DE:SHL)
XETRA:SHL
SHL Stock Chart & Stats
Day’s Range― - ―
52-Week Range€47.31 - €58.14
Previous CloseN/A
Volume31.64K
Average Volume (3M)621.91K
Market Cap
$59.67B
Enterprise Value€74.05B
Total Cash (Recent Filing)211.00M
Total Debt (Recent Filing)15.00M
Price to Earnings (P/E)30.8
Beta1.06
Next Earnings
Feb 06, 2025EPS Estimate
0.47Next Dividend Ex-Date
Feb 19, 2025Dividend Yield1.81%
Share Statistics
EPS (TTM)1.74
Shares Outstanding1,128,000,000
10 Day Avg. Volume656,751
30 Day Avg. Volume621,907
Standard Deviation0.07
R-Squared0.05
Alpha0.00706
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€60.25Price Target Upside11.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Siemens Healthineers AG News
PremiumCompany Announcements
Siemens Healthineers Reports Strong Fiscal Year 2024
PremiumPre-Earnings
Is SEMHF a Buy, Before Earnings?
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceForecast of 5.1% organic growth leading to a new record sales quarter driven by new deals and overcoming supply chain disruptions.
Market ValuationThe lowest relative valuation seen in three years is paired with the most premium growth.
Product DevelopmentThe next catalyst for Siemens Healthineers will be the expected unveiling of the new Photon-counting CTs, which could strengthen the company's market position.
Bears Say
Internal CompetitionDiagnostics remains unchanged in 1Q:F25 organic growth estimate at 2.5%, with a note that Atellica continues to cannibalize the Legacy diagnostics business.
Market ChallengesChina growth remains elusive with previous 'China' driven guides having disappointed.
Regulatory ImpactA conservative view is taken for the first half of the fiscal year due to the potential impact of China's anti-corruption campaign, leading to expectations of weaker performance compared to the second half.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
3.29% Mutual Funds
― Other Institutional Investors
94.23% Public Companies and
Individual Investors
SHL FAQ
What was Siemens Healthineers AG’s price range in the past 12 months?
Siemens Healthineers AG lowest stock price was €47.31 and its highest was €58.14 in the past 12 months.
What is Siemens Healthineers AG’s market cap?
Siemens Healthineers AG’s market cap is $59.67B.
When is Siemens Healthineers AG’s upcoming earnings report date?
Siemens Healthineers AG’s upcoming earnings report date is Feb 06, 2025 which is tomorrow.
How were Siemens Healthineers AG’s earnings last quarter?
Siemens Healthineers AG released its earnings results on Nov 06, 2024. The company reported €0.67 earnings per share for the quarter, beating the consensus estimate of €0.641 by €0.029.
Is Siemens Healthineers AG overvalued?
According to Wall Street analysts Siemens Healthineers AG’s price is currently Undervalued.
Does Siemens Healthineers AG pay dividends?
Siemens Healthineers AG pays a Annually dividend of €0.949 which represents an annual dividend yield of 1.81%. See more information on Siemens Healthineers AG dividends here
What is Siemens Healthineers AG’s EPS estimate?
Siemens Healthineers AG’s EPS estimate is 0.47.
How many shares outstanding does Siemens Healthineers AG have?
Siemens Healthineers AG has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers AG’s price movement after its last earnings report?
Siemens Healthineers AG reported an EPS of €0.67 in its last earnings report, beating expectations of €0.641. Following the earnings report the stock price went up 5.953%.
Which hedge fund is a major shareholder of Siemens Healthineers AG?
Currently, no hedge funds are holding shares in DE:SHL
---
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€60.25 (11.49% Upside)
€60.25 (11.49% Upside)
Blogger Sentiment
Bullish
DE:SHL Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $422.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.08%
12-Months-Change
Fundamentals
Return on Equity
10.68%
Trailing 12-Months
Asset Growth
3.99%
Trailing 12-Months
Company Description
Siemens Healthineers AG
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
---
SHL Company Deck
---
SHL Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in Q4 with significant growth and improvements across several segments, particularly in Imaging and Varian. However, challenges in the China market posed a significant headwind, affecting overall growth. Despite this, the company demonstrated resilience and maintained a positive outlook for 2025.Read More>---
SHL Stock 12 Month Forecast
Average Price Target
€60.25
▲(11.49% Upside)
Technical Analysis
Qiagen
―
Biotest
―
Draegerwerk AG & Co. KGaA
―
Fresenius Medical Care AG & Co. KGaA
―
Fresenius SE & Co. KGaA
―
Best Analysts Covering SHL
1 Year
1 Year Success Rate
17/24 ratings generated profit
1 Year Average Return
+13.42%
reiterated a buy rating 7 days ago
Copying Lisa Bedell Clive's trades and holding each position for 1 Year would result in 70.83% of your transactions generating a profit, with an average return of +13.42% per trade.
---